A new case series explores the efficacy of immune checkpoint inhibitors in treating invasive mucinous adenocarcinoma. This research contributes to understanding potential therapeutic options for this rare cancer type.
immune checkpoint inhibitors for invasive mucinous adenocarcinoma a case series
Original title: “Immune checkpoint inhibitors for invasive mucinous adenocarcinoma: A case series.”